TSC2 oncogenic variants
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | TSC2 oncogenic variants | Renal Angiomyolipoma | Everolimus | |
| FDA (1) | TSC2 oncogenic variants | Subependymal Giant Cell Astrocytoma | Everolimus |